High kallikrein-related peptidase 6 in non-small cell lung cancer cells: An indicator of tumour proliferation and poor prognosis

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 9 B, 2009, Pages 4014-4022

  Nathalie, Heuzé Vourc'h ^a   Chris, Planque ^a   Serge, Guyetant ^a   Catherine, Coco ^a   Benjamin, Brillet ^a   Claire, Blechet ^a   Christelle, Parent ^a   Briollais, Laurent ^b   Pascale, Reverdiau ^a   Marie Lise, Jourdan ^a   Yves, Courty ^a  

^a UNIVERSITÉ DE TOURS   (France)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

C Myc; Cell cycle; Cell proliferation; Cyclin; Kallikrein related peptidase; KLK6; NSCLC; Overexpression; Survival

Indexed keywords

CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; KALLIKREIN; KLK6 PROTEIN, HUMAN; MYC PROTEIN;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CELL CYCLE; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; LUNG; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KALLIKREINS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 77649147259     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00763.x     Document Type: Article

References (33)

1. Borgono CA, Diamandis EP. The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer. 2004, 4:876-90.
2. Hutchinson S, Luo LY, Yousef GM. Purification of human kallikrein 6 from biological fluids and identification of its complex with alpha(1)-antichymotrypsin. Clin Chem. 2003, 49:746-51.
3. Petraki CD, Karavana VN, Skoufogiannis PT. The spectrum of human kallikrein 6 (zyme/protease M/neurosin) expression in human tissues as assessed by immunohistochemistry. J Histochem Cytochem. 2001, 49:1431-41.
4. Petraki CD, Papanastasiou PA, Karavana VN. Cellular distribution of human tissue kallikreins: immunohistochemical localization. Biol Chem. 2006, 387:653-63.
5. Shaw JL, Diamandis EP. Distribution of 15 human kallikreins in tissues and biological fluids. Clin Chem. 2007, 53:1423-32.
6. Singh J, Naran A, Misso NL. Expression of kallikrein-related peptidases (KRP/hK5, 7, 6, 8) in subtypes of human lung carcinoma. Int Immunopharmacol. 2008, 8:300-6.
7. Paliouras M, Diamandis EP. The kallikrein world: an update on the human tissue kallikreins. Biol Chem. 2006, 387:643-52.
8. Hoffman BR, Katsaros D, Scorilas A. Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker. Br J Cancer. 2002, 87:763-71.
9. Santin AD, Diamandis EP, Bellone S. Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer. Clin Cancer Res. 2005, 11:3320-5.
10. Zarghooni M, Soosaipillai A, Grass L. Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer's disease patients. Clin Biochem. 2002, 35:225-31.
11. Klucky B, Mueller R, Vogt I. Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion. Cancer Res. 2007, 67:8198-206.
12. Nagahara H, Mimori K, Utsunomiya T. Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer. Clin Cancer Res. 2005, 11:6800-6.
13. Ghosh MC, Grass L, Soosaipillai A. Human kallikrein 6 degrades extracellular matrix proteins and may enhance the metastatic potential of tumour cells. Tumour Biol. 2004, 25:193-9.
14. Klokk TI, Kilander A, Xi Z. Kallikrein 4 is a proliferative factor that is overexpressed in prostate cancer. Cancer Res. 2007, 67:5221-30.
15. Planque C, de Monte M, Guyetant S. KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancer. Biochem Biophys Res Commun. 2005, 329:1260-6.
16. Planque C, Aïnciburu M, Heuzé-Vourc'h N. Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues. Biol Chem. 2006, 387:783-8.
17. Barascu A, Besson P, Le Floch O. CDK1-cyclin B1 mediates the inhibition of proliferation induced by omega-3 fatty acids in MDA-MB-231 breast cancer cells. Int J Biochem Cell Biol. 2006, 38:196-208.
18. Heuzé-Vourc'h N, Liu M, Dalwadi H. IL-20, an anti-angiogenic cytokine that inhibits COX-2 expression. Biochem Biophys Res Commun. 2005, 333:470-5.
19. Cox DR. Regression models with life tables. J R Stat Soc. 1972, 34:187-220.
20. Heuzé-Vourc'h N, Aïnciburu M, Planque C. Recombinant kallikrein expression: site-specific integration for hK6 production in human cells. Biol Chem. 2006, 387:687-95.
21. Zajac-Kaye M. Myc oncogene: a key component in cell cycle regulation and its implication for lung cancer. Lung Cancer. 2001, 34:S43-6.
22. Pelengaris S, Khan M, Evan G. c-MYC: more than just a matter of life and death. Nat Rev Cancer. 2002, 2:764-76.
23. Gartel AL, Shchors K. Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes. Exp Cell Res. 2003, 283:17-21.
24. Planque C, Bléchet C, Ayadi-Kaddour A. Quantitative RT-PCR analysis and immunohistochemical localization of the kallikrein-related peptidases 13 and 14 in lung. Biol Chem. 2008, 389:781-6.
25. Sher YP, Chou CC, Chou RH. Human kallikrein 8 protease confers a favorable clinical outcome in non-small cell lung cancer by suppressing tumor cell invasiveness. Cancer Res. 2006, 66:11763-70.
26. Li B, Goyal J, Dhar S. CpG methylation as a basis for breast tumor-specific loss of NES1/kallikrein 10 expression. Cancer Res. 2001, 61:8014-21.
27. Smiraglia DJ, Rush LJ, Frühwald MC. Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum Mol Genet. 2001, 10:1413-9.
28. Pampalakis G, Sotiropoulou G. Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer. Biol Chem. 2006, 387:773-82.
29. Tlsty TD, Coussens LM. Tumor stroma and regulation of cancer development. Annu Rev Pathol. 2006, 1:119-50.
30. Pampalakis G, Sotiropoulou G. Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer. Biochim Biophys Acta. 2007, 1776:22-31.
31. Blagosklonny MV, Pardee AB. The restriction point of the cell cycle. Cell Cycle. 2002, 1:103-10.
32. Parkin DM, Bray F, Ferlay J. Global cancer statistics, 2002. CA Cancer J Clin. 2005, 55:74-108.
33. Planque C, Li L, Zheng Y. A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma. Clin Cancer Res. 2008, 14:1355-62.